Commercial

GSK announces first approval of Shingrix in Canada

October 16, 2017

GlaxoSmithKline plc (LSE/NYSE: GSK) today announced that Shingrix has been approved in Canada for the prevention of shingles (herpes zoster) in people aged 50 years or older.[i] Shingrix is a non-live, recombinant subunit adjuvanted vaccine given intramuscularly in two doses. Shingles is caused by reactivation of the varicella zoster virus, the same virus that causes […]

Prime Therapeutics Study Finds a Diabetes Drugs Value Based Insurance Design Improves Adherence, Doesn’t Lower Total Cost of Care

October 16, 2017

PAUL, MINN. – Oct. 13, 2017 – Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM) serving more than 20 million members nationally, found that implementing value based insurance designs (VBID) does not lead to lower total cost of care for members. VBID are benefits designed to maximize quality and decrease costs of health care […]

Janssen Announces U.S. FDA Approval Of STELARA® (ustekinumab) For The Treatment Of Adolescents With Moderate To Severe Plaque Psoriasis

October 16, 2017

HORSHAM, Pa., Oct. 13, 2017 /PRNewswire/ — Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for STELARA® (ustekinumab) for the treatment of adolescents (12 years of age or older) with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Today’s approval […]

Janssen Announces U.S. FDA Approval Of STELARA® (ustekinumab) For The Treatment Of Adolescents With Moderate To Severe Plaque Psoriasis

October 16, 2017

HORSHAM, Pa., Oct. 13, 2017 /PRNewswire/ — Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for STELARA® (ustekinumab) for the treatment of adolescents (12 years of age or older) with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. Today’s approval […]

GervanoRA Data Services (GDS) Projects Germany’s Pharmaceutical Market is the Largest in Europe and is Expected to Reach $63.3 Billion by 2022

October 16, 2017

GOA, India, October 16, 2017 /PRNewswire/ —   According to a new country specific report “GER0004CI Germany Insights: Healthcare Industry, Policies, Regulations and PESTLE Analysis” published by GervanoRA Data Services (GDS), Germany’ pharmaceutical market is expected to reach $63.3 billion by 2022.   Germany’s healthcare market is the largest in Europe and fourth largest in […]

Galderma Announces FDA Approval of Restylane® Silk as the First HA Dermal Filler Approved for Injection via Cannula

October 13, 2017

FORT WORTH, Texas, Oct. 12, 2017 /PRNewswire/ — Galderma, a global leader focused on medical solutions in skin health, announced today it has received U.S. Food and Drug Administration (FDA) approval for the use of a small blunt tip cannula with Restylane® Silk for lip augmentation.2 Restylane® Silk was the first FDA-approved hyaluronic acid (HA) […]

Global Idiopathic Pulmonary Fibrosis Market Expected to Reach $3,569 Million by 2023 – Allied Market Research

October 13, 2017

PORTLAND, Oregon and PUNE, India, October 12, 2017 /PRNewswire/ —   According to a new report published by Allied Market Research, titled, “Idiopathic Pulmonary Fibrosis Market by Type of Drug: Global Opportunity Analysis and Industry Forecast, 2017-2023,” the global idiopathic pulmonary fibrosis market was valued at $1,616 million in 2016, and is projected to reach […]

Epigenetics Market Worth 1,605.7 Million USD by 2022

October 13, 2017

PUNE, India, October 12, 2017 /PRNewswire/ —   According to a new market research report “Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) – Global Forecast to 2022”, published by MarketsandMarkets™, the market is projected to reach USD […]

Sharing Negotiated Discounts Could Save Patients More than $800 Annually and Would Increase Premiums About 1 Percent

October 13, 2017

WASHINGTON, Oct. 12, 2017 /PRNewswire-USNewswire/ — Providing access to discounted medicine prices at the point of sale could save certain commercially insured patients with high deductibles and coinsurance $145 to more than $800 annually, according to a new analysis from Milliman that was commissioned by the Pharmaceutical Research and Manufacturers of America (PhRMA). The data […]

Locating Patients with Rare Diseases

October 13, 2017

Why a Qualitative Lead Generation Approach Is a Must-Have Component of Any Orphan Drug Sales Strategy Finding patients with rare diseases requires both a quantitative and a qualitative approach. By taking analytics one step further and using a hands-on approach, TrialCard’s Virtual Engagement team has identified health care professionals (HCPs) currently treating patients with rare […]

FDA Advisory Committee Unanimously Recommends Approval of Investigational LUXTURNA™ (voretigene neparvovec) for Patients with Biallelic RPE65-mediated Inherited Retinal Disease

October 13, 2017

PHILADELPHIA, Oct. 12, 2017 — Spark Therapeutics (NASDAQ: ONCE), a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that the U.S. Food and Drug Administration’s (FDA) Cellular, Tissue and Gene Therapies Advisory Committee has unanimously recommended (16-0) approval of LUXTURNA™ (voretigene neparvovec), an investigational, potential one-time gene therapy, […]

New Diabetes Therapeutics to Steal Ground from Insulin Therapies, says GBI Research

October 13, 2017

The incidence of diabetes mellitus (DM), and most notably type 2 diabetes mellitus (T2DM), which accounts for 90–95% of all DM cases, is growing rapidly on a global scale, according to business intelligence provider GBI Research. The company’s latest report: ‘Global Diabetes Drugs Market to 2023 – A Diversifying Treatment Landscape as GLP-1 Receptor Agonists […]

Dr. Ron Jurgensen, Newport Beach Dentist Celebrates 30 Years of Humanitarian Service in Third-World Countries – Offering Hope Where there is None

October 13, 2017

Dr. Ron Jurgensen, Newport Beach Dentist Celebrates 30 Years of Humanitarian Service in Third-World Countries – Offering Hope Where there is None Every year for the past 30 years, Dr. Jurgensen has spent his vacations relieving the unimaginable suffering of impoverished people who have no access to dental care or hygiene. Newport Beach, Calif., October […]

U.S. FDA Approves LYRICA® CR (pregabalin) Extended-Release Tablets CV New formulation may offer convenience to patients

October 12, 2017

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) announced today that the United States Food and Drug Administration (FDA) has approved LYRICA® CR (pregabalin) extended-release tablets CV as once-daily therapy for the management of neuropathic pain associated with diabetic peripheral neuropathy (pDPN) and the management of postherpetic neuralgia (PHN). LYRICA CR did not receive approval for the […]

Shionogi Inc. and Purdue Pharma L.P. Announce U.S. Availability of Symproic® (naldemedine) for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-Cancer Pain

October 12, 2017

OSAKA, Japan & FLORHAM PARK, N.J. & STAMFORD, Conn.–(BUSINESS WIRE)–Shionogi Inc. and Purdue Pharma L.P. announced today that Symproic® (naldemedine) 0.2 mg tablets are now available throughout the United States. The U.S. Food and Drug Administration (FDA) approved Symproic as a once-daily oral tablet for the treatment of opioid-induced constipation (OIC) in adult patients with […]

Indonesian Pharmaceutical Market Value to Reach $10.11 billion by 2021, says GlobalData

October 12, 2017

Indonesia’s pharmaceutical market is the largest market in the Association of Southeast Nations (ASEAN) and is expected to reach $10.11 billion by 2021, according to GlobalData, a recognized leader in providing business information and analytics. The company’s latest report: ‘CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Indonesia’ offers an essential source of information and analysis […]

Global Diabetes Therapeutics Market Expected to Reach $186,842 Million by 2023 – Allied Market Research

October 12, 2017

PORTLAND, Oregon and PUNE, India, October 11, 2017 /PRNewswire/ —   According to a new report published by Allied Market Research, titled, “Diabetes Therapeutics Market: Global Opportunity Analysis and Industry Forecast, 2017-2023,” the global diabetes therapeutics market was valued at $66,993 million in 2016, and is estimated to reach $186,842 million by 2023, growing at […]

Legal Fight Looms Over California’s New Drug Pricing Law

October 12, 2017

California passed a law requiring pharmaceutical companies to explain their price increases, escalating the state-by-state battle between lawmakers trying to bring more transparency to the industry’s practices and drugmakers that oppose the efforts.   The California measure, signed Monday by Governor Jerry Brown, is among the most aggressive state efforts to peel back the secretive […]

Janssen Research & Development Establishes First-of-Its-Kind Mobile Medication and Data Management Technology Platform for Industry Use iSTEP’s mobile technologies designed to improve trial efficiencies and speed drug development

October 12, 2017

RARITAN, N.J., Oct. 11, 2017 /PRNewswire/ — Janssen Research & Development, LLC (Janssen) today announced that it has established the Integrated Smart Trial & Engagement Platform (iSTEP), a first-of-its-kind information technology toolset developed to automate investigational product supply and data management in clinical trials. The approach, developed by Janssen, is available for industry-use and is […]

Amazon is on the brink of deciding if it will make a big move into selling drugs online

October 12, 2017

Amazon’s push into pharmacy is very much an “if” and not a “when,” sources say. The company spends years researching opportunities before it telegraphs its intentions. The drug supply chain is particularly complex, with regulatory hurdles and entrenched competition.   Amazon is in the final stages of figuring out its strategy to get into the […]

Sword and Medexprim : combining clinical and imaging data in big-data research projects

October 12, 2017

Sword Group and Medexprim are partnering in view to offer cancer centers and large hospitals a unified solution to facilitate translational research, combining clinical and imaging data. SWORD GROUP has developed the innovative solution ConSoRe, in partnership with Unicancer, which federates 20 French leading not-for profit private cancer hospitals (« centres de lutte contre le cancer», http://www.unicancer.fr/unicancer) in France.  ConSoRe is an evolved […]

CRF Health Appoints Key Executives Following Business Growth and Investment

October 12, 2017

Plymouth Meeting, PA – October 12, 2017:  CRF Health, a leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, has made two senior appointments to support the continuing growth of the global business. CRF Health will expand its operations team with the addition of Neil Conroy as VP of […]

Blueprint Medicines Announces Appointment of Christopher Murray, Ph.D. as Senior Vice President, Technical Operations

October 11, 2017

CAMBRIDGE, Mass., Oct. 10, 2017 /PRNewswire/ — Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced the appointment of Christopher Murray, Ph.D. as Senior Vice President, Technical Operations. Dr. Murray will join the executive management team and be responsible for technical development, […]

FEEDBACK